About Diatech Diabetes
Diatech Diabetes is a private company based in Memphis, Tennessee, incorporated in 2019 in Delaware. It has reported $325,000 raised in five offerings on Form D since May 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 22, 2024 | Jul 25, 2024 | $100,000of $150K target | 2 | $50,000 | DebtRule 506(b) | Form D ↗ |
| Jun 6, 2021 | Aug 12, 2021 | $25,000fully sold | 1 | $25,000 | OptionsRule 506(b) | Form D ↗ |
| Mar 31, 2020 | Apr 17, 2020amended Jun 18, 2020 | $100,000fully sold | 2 | $50,000 | OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 17, 2019 | Oct 22, 2019 | $25,000fully sold | 1 | $25,000 | OptionsRule 506(b) | Form D ↗ |
| May 14, 2019 | May 28, 2019 | $75,000fully sold | 2 | $37,500 | OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $325,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Diatech Diabetes's Form D filed Jul 25, 2024.
LB
Luis Blanco
Director
JW
John Wilcox
Executive officer and director
Earlier filings also listed Nicholas Cooper (executive officer and director, last listed Aug 2021) and John Gray (director, last listed Aug 2021).